cambridge's bluebird bio licenses delivery tech to novartis, gsk
. november 17, 2014
.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
suven life sciences' pashamylaram facility successfully completes usfda inspection